Thanks to the entire team! We've already supported many @ishamycology.bsky.social & #ECMM projects with our capacity for multinational collaborative research and we're always happy to support new collaborations. www.nature.com/articles/s41... @salmantongarcia.bsky.social @natcomms.nature.com

Fungal diagnostics and antifungal drug access in Latin America and the Caribbean: an ESCMID EFISG multinational survey - Nature Communications

Here, in a survey of 619 institutions across Latin America and the Caribbean, the authors showcase major gaps in fungal diagnostics and antifungal access, with stark disparities linked to income and i...

nature.com

Is your home affected by dampness? 🏠💧 Take part in a Europe-wide citizen science survey to help researchers better understand damp housing and its impact on health. It only takes a few minutes! Please share. www.clinicalsurveys.net/uc/DampHome/ #CitizenScience #PublicHealth

Fungal diseases are shaped by environmental, agricultural and social factors. Domain 4 of the WHO Blueprint promotes a One Health approach to reduce risk and strengthen resilience. www.who.int/publications... #OneHealth #AMR

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

who.int

A new episode of the ISHAM Pioneers in Mycology series is out! Prof. Ariya Chindamporn shares her journey from agricultural sciences to becoming a pioneer in medical mycology, advancing fungal diagnostics, education, and collaboration across Southeast Asia. youtu.be/mvtN6uQ_K6o

ISHAM Pioneers in Mycology – Interview with Ariya Chindamporn

YouTube video by IDIM IDIM

youtu.be

📅 Join the #NIAID workshop Improving Clinical Outcomes for Mucormycosis and Other Rare Mold Infections (Aug 13–14, hybrid). Help shape the future of rare mold infection research. Register: cvent.me/2189Gn #Mucormycosis #ClinicalResearch #Mycology

⏰ One week left! If you work in #MedicalMycology, please share your career & workplace experiences in the WIM × Womyc survey. Your voice will help shape a stronger community. ⏱️ ~11 min | 🔒 Anonymous | 📅 Closes 31 July www.clinicalsurveys.net/uc/wim-womyc...

Better data saves lives. Domain 3 of the WHO Blueprint strengthens laboratory capacity, surveillance and outbreak preparedness to improve detection of fungal diseases and antifungal resistance. www.who.int/publications... #Surveillance #AMR

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

who.int

Innovation only matters if patients can benefit from it. Domain 2 of the WHO Blueprint focuses on research, regulation and equitable access to antifungal medicines and diagnostics. www.who.int/publications... #Innovation #AMR

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

who.int

📢 Jetzt zur MYK 2026 anmelden! Die 60. Wissenschaftliche Jahrestagung der Deutschsprachigen Mykologischen Gesellschaft findet vom 17.–19.09.2026 an der Medizinischen Universität Graz statt. 👉 dmykg-kongress.de/registrierung #MYK2026 #DMykG #Mykologie

New in Mycoses: A pooled Phase 2/3 analysis shows rezafungin was non-inferior to caspofungin for invasive candidiasis and candidaemia, with earlier mycological eradication and a comparable safety profile. Read more: doi.org/10.1111/myc.... #Mycoses #IDTwitter #MedMycology #Antifungals

Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials

Background The efficacy and safety of rezafungin in invasive candidiasis (IC) and candidaemia was demonstrated in the Phase 2 STRIVE and Phase 3 ReSTORE trials, and an additional cohort of patients ...

doi.org

🗓️ 06.10.2026 | Berlin Wie schützen wir Wissenschaft und Demokratie vor Desinformation und Angriffen auf die Wissenschaftsfreiheit? Diskutieren Sie mit beim Symposium „Wissenschaft pro Demokratie“. Anmeldung bis 22.09.: wpd-symposium.de #Wissenschaft #Demokratie #Science

Stronger health systems start with better fungal disease recognition, infection prevention, antifungal stewardship and equitable access to diagnostics and medicines. Explore Domain 1 of the WHO Blueprint: www.who.int/publications... #AMR

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

who.int

⏳ Only 2 days left for the #ISHAMAsia2026 Early Bird rate! I'll be in Kuala Lumpur and hope to see many of you there. Use code FA10IA26 for an extra 10% off your registration. Register: isham.asia

📢 Kostenloses Webinar am 14. Juli | 17:00–18:15 Uhr Harnwegsinfekte: Welche Rolle spielt das Mikrobiom? Mit PD Dr. Lena Biehl. Aktuelle Erkenntnisse und neue Therapieansätze bei rezidivierenden Harnwegsinfektionen. Anmeldung: us06web.zoom.us/webinar/regi...

Welcome! You are invited to join a webinar: Harnwegsinfekte: Welche Rolle spielt das Mikrobiom? . After registering, you will receive a confirmation email about joining the webinar.

Harnwegsinfektionen sind eine der häufigsten bakteriellen Infektionen sowohl im stationären wie ambulanten Bereich. Insbesondere bei wiederkehrenden Harnwegsinfektionen zeigt die aktuelle Forschung ei...

us06web.zoom.us

Registration is now open for the NIAID workshop Improving Clinical Outcomes for #Mucormycosis and Other Rare #Mold Infections (Aug 13–14, hybrid). Join experts to shape future clinical research and trial infrastructure. Register: cvent.me/2189Gn

🌍 Help shape the future of #OneHealth & #PlanetaryHealth education! If you're a health professional, educator or student, please take this 10-minute global survey coordinated by the WVA and partners. 🔗 redcap.uasz.sn/surveys/?s=J... Please share! #GlobalHealth

A major step forward in tackling fungal diseases and antifungal resistance. The new WHO Implementation Blueprint translates the Fungal Priority Pathogens List into practical action across health systems, laboratories, innovation and One Health. www.who.int/publications... #AMR #FungalDiseases

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengthening coordinated responses to fungal disease and antifungal resistance (AFR).

who.int

And the same for authors and books

Wir freuen uns über den Beitrag von KölnTourismus zu unserem Freiwilligenregister v-reg! 🙌 Jetzt informieren: location.koelntourismus.de/veranstaltun... Mitmachen: v-reg.eu #KlinischeForschung #Studienteilnahme

Forschungsprojekt VACCELERATE des CECAD abgeschlossen | locations.koeln

Ziel des Projekts war es, eine europaweite Forschungsinfrastruktur für klinische Impfstoffstudien aufzubauen. Hier mehr erfahren.

location.koelntourismus.de

📢 Work in medical mycology? Share your career and workplace experiences in the joint WIM × Womyc survey. Open to all career stages, backgrounds & genders. Anonymous, ~11 min. Closes July 31. Your voice matters! 🔗 www.clinicalsurveys.net/uc/wim-womyc...

The 9th edition of the #TBE Book is now available online. 📘 An updated, free, evidence-based reference on tick-borne encephalitis for clinicians, researchers, and public health professionals. tbenews.com/tbe/ #TickBorneEncephalitis #PublicHealth #InfectiousDiseases #OpenAccess

The TBE Book 9th Edition - TBE Book

Gerhard Dobler Wilhelm Erber Michael Bröker Lidia Chitimia-Dobler Heinz-Josef Schmitt Introduction Welcome to the 9th Edition of “The TBE Book” Read More List of contents List of contributing authors ...

tbenews.com

📍 Gastrointestinale Infektionen sicher managen – zwischen Praxis und Klinik. Am 8. Juli treffen sich Expert:innen in Düsseldorf zum Austausch über Hepatitis, Darmmikrobiom und klinisches Management. Hybrid teilnehmen möglich. 🔗 swp-hl.de/meet/intojuli

New in the @ishamycology.bsky.social Pioneers in Mycology series: Prof. Flavio Queiroz-Telles reflects on his career, endemic mycoses, fungal disease recognition, and the future of medical mycology. Watch now and explore the full series: www.isham.org/about-isham/... #MedMycology #FungalDiseases

@salmantongarcia.bsky.social represented our team at the #EHA2026 Congress in Stockholm, connecting with leading experts and exploring the latest developments in hematology. Great conversations, valuable insights, and new perspectives to bring back to our work. #Hematology #Healthcare

I’m excited to be attending ISHAM Asia 2026 in Kuala Lumpur, Malaysia, where experts in medical mycology will share the latest advances in fungal disease diagnosis and management. 🎟️ Get 10% off registration with referral code: FA10IA26 isham.asia @ishamycology.bsky.social

The @ishamycology.bsky.social Pioneers in Mycology interview series celebrates the scientists who shaped modern medical mycology. Hear their stories, insights, and lessons for future generations. More interviews are coming in the months ahead. www.isham.org/about-isham/...

KIT 2026 in Köln: Die ersten beiden Kongresstage liegen hinter uns – mit spannenden Vorträgen, neuen Impulsen und vielen wertvollen Begegnungen. Danke für den bisherigen Austausch – wir freuen uns auf morgen! 📸 #KIT2026 #Infektiologie #Köln

📍 KIT 2026 – Posterkurzvortragssitzung „Scores, Visiten und Boards“ Morgen, 19.06.2026 @jannikstemler.bsky.social: „Etablierung einer interdisziplinären Fallkonferenz zur Verbesserung des Managements invasiver Mykosen“ 🕒 15:37–15:44 | Gewölbetraum, Ebene 00 Programm: kit-kongresse.de/wissenschaft...

Wissenschaftliches Programm - KIT Kongresse 2026

Legende

kit-kongresse.de

Positive topline results from the Phase 3 #OASIS trial evaluating oral #olorofim for invasive #aspergillosis. The study met its primary endpoint. We are pleased to have contributed to patient enrollment in Cologne. #ClinicalTrials #FungalInfections f2g.com/press-releas...

F2G and Shionogi Announce Positive Topline Results from Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients with Invasive Aspergillosis | F2G.

The study achieved the primary endpoint of non-inferiority, with a rate of all-cause mortality (ACM) at Day 42 for olorofim of 23.8% and for AmBisome® follo ...

f2g.com

Glückwunsch an Miranda Anggitakirana zu einem hervorragenden Posterkurzvortrag auf der Sitzung „Impfungen und virale (Atemwegs)Infektionen“ beim #KIT2026. Die Präsentation zu Punktprävalenzen von fünf respiratorischen Viren bei Erwachsenen ≥50 Jahren in DE war klar, präzise und absolut überzeugend.👏